Pritzker signs bill to end step therapy for Alzheimer's patients in Illinois
SPRINGFIELD, Ill. (WTVO) — Starting next month, Alzheimer's patients with state insurance in Illinois will have access to new FDA-approved treatment and medicine.
Gov. JB Pritzker signed a bill into law on Tuesday that would eliminate 'step therapy,' meaning patients will no longer have to try cheaper drugs before taking medication prescribed by their doctor.
Advocates for the law said it will save patients money.
David Olsen, of the Alzheimer's Association Illinois Chapter, said, 'Because these are expensive treatments where the average person doesn't have access to them unless their insurance is going to pay for it whether that's through Medicare, Medicaid, or private insurance.'
The law will also cover diagnostic testing needed to confirm an Alzheimer's diagnosis, beginning in 2027.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Miami Herald
an hour ago
- Miami Herald
Augnition Labs Announces FDA Classification for Flagship Product, AugMem(TM)
NEW YORK CITY, NEW YORK / ACCESS Newswire / June 12, 2025 / Augnition Labs, a neurotechnology company developing science-driven tools to advance cognitive health, today announced that its flagship product, AugMem™, has been classified by the FDA as a Prescription Use Cognitive Assessment Aid (PTY). This significant milestone paves the way for clinical deployment to support evaluation of cognitive function and help identify changes that may indicate early cognitive decline. Grounded in more than two decades of neuroscientific research by Co-Founder and Chief Scientific Advisor, Dr. Michael Yassa, AugMem™ evaluates pattern separation - a core brain process that enables us to form distinct memories. Subtle impairments in this mechanism often precede clinical symptoms of cognitive decline by 10-15 years. "Early detection is critical. If we wait until memory loss is obvious, decline can be irreversible," said Yassa. "This FDA classification is a major step forward. It opens the door for us to deploy it in healthcare settings. Our goal is to make ultrasensitive cognitive assessment available where it's needed most-at the frontlines of care, before symptoms become disabling." In addition to this regulatory milestone, Augnition Labs also announced key leadership appointments to strengthen its path to growth and impact. Ernst Wodrada, a seasoned executive in the medical technology industry, has joined Augnition as President. Ernst brings leadership experience from global healthcare organizations, including Philips, where he led efforts in imaging, image-guided therapy, and healthcare innovation. "I am honored and excited to join Augnition Labs, working alongside this fantastic team to forge meaningful partnerships with clinical experts and investors," Wodrada said. "Cognitive decline presents profound challenges, and together, we are committed to pioneering solutions that empower individuals and caregivers." Ali Kennedy Scott, a member of Augnition's founding team, will step into the role of Managing Director. A former Bain & Company consultant, Kennedy Scott brings expertise in growth strategy, organizational effectiveness, and customer insight, with experience spanning healthcare, consumer products, and private equity-backed ventures. The company also welcomes Dr. Chris Bun as Head of Technology. With a background in AI, machine learning, and healthcare technology, Dr. Bun will lead development of Augnition's core platform, applying advanced AI and user-centered design to cognitive assessment tools. "We are deeply proud of the momentum behind AugMem™ and of this team that's come together to shape the future of cognitive assessments," said Kennedy Scott. "This FDA classification is a foundational step in our mission to equip patients, caregivers, and healthcare providers with tools that enhance clarity, agency, and hope." Augnition collaborates with leading academic institutions, industry researchers, clinicians, and healthcare systems to create accessible, evidence-based tools for cognitive health. About Augnition LabsAugnition Labs develops science-driven tools to advance cognitive health. The company was founded on the scientific work of Dr. Michael Yassa, a globally recognized expert in the neurobiology of memory and Alzheimer's Disease. With a focus on clinical utility, human-centered design, and early intervention, Augnition empowers patients, researchers, and clinicians to better understand the brain and respond to change. SOURCE: Augnition Labs press release
Yahoo
an hour ago
- Yahoo
Here's how the House GOP's proposed Medicaid cuts could impact Minnesota
Thousands of protestors gathered at the Minnesota State Capitol as part of the nationwide "Hands Off" protests condemning several actions of the Trump administration Saturday, April 5, 2025. (Photo by Nicole Neri/Minnesota Reformer) Minnesota could lose up the half a billion dollars annually if a GOP-backed tax bill becomes federal law, Minnesota's Medicaid director warned Thursday. That could mean fewer services or tighter restrictions on eligibility, affecting health care for hundreds of thousands of Minnesotans and the hospitals and other providers that treat them. The bill, which has already passed the U.S. House on a 215-214 vote, is still far off from becoming law; Senate Republicans are drafting their own version, and the GOP remains deeply split over how to pay for tax cuts, which is their ultimate goal. For now, the House legislation is the most detailed public plan for how Republicans will fund an extension of President Donald Trump's 2017 tax cuts, plus a bunch more. The tax cuts passed by the House would decrease federal revenue by about $3.7 trillion over the next ten years, according to the nonpartisan Congressional Budget Office. To offset the loss of income, Republicans want to cut spending by $1.3 trillion, mostly by targeting Medicaid and SNAP, which helps low-income people buy food. (The $2.4 trillion gap between the revenue and spending cuts would be added to the federal debt, which will in turn increase what taxpayers must shell out in interest payments, which have surpassed $1 trillion annually.) Medicaid pays for health care for the elderly, low-income and disabled. The cost is shared between states and the federal government; last year, Minnesota spent $18 billion on Medical Assistance, which is Minnesota's version of Medicaid. The federal government covered $11 billion of that. More than 1.2 million Minnesotans rely on Medical Assistance, and deep cuts would cause 'serious harm' to Minnesotans, said John Connolly, Minnesota's Medicaid director. 'Our position at the Minnesota Department of Human Services is that the bill currently on the table is inefficient, ineffective and fundamentally unfair,' Connolly said during a press briefing. Minnesota is already grappling with how to pay for care for an aging population as health care costs continue to rise. The state Legislature made $270 million in cuts to Medical Assistance this year, as spending on the program has risen faster than tax revenues. DHS estimates that if the U.S. House tax bill were to become law, the state would lose out on $500 million per year. The bill would cause between 152,000 and 253,000 Minnesotans to lose health insurance, according to Kaiser Family Foundation. It would also push costs onto state and local governments, Connolly said, by requiring county and tribal governments to verify participants' eligibility twice as often as they do now, and increasing the administrative burden for the state. The largest chunk of the possible cuts to Minnesota comes from a provision that would reduce Medicaid reimbursements for states that subsidize health insurance for undocumented people. The Legislature voted this week to remove eligibility of undocumented adults for MinnesotaCare, a state- and federally-funded health insurance program for the working poor that is separate from Medical Assistance. As long as undocumented children remain eligible for MinnesotaCare — and if the House language becomes law — Minnesota would still have its federal funding cut by about $330 million, according to DHS. Senate Republicans are wary of deep Medicaid cuts, and are instead expected to target SNAP, the New York Times reported Thursday. The Senate has not yet introduced its version of the tax bill. A proposal to shift 25% of federal SNAP benefit costs onto states would shift up to $220 million annual cost to Minnesota, according to the state Department of Youth and Family Services. More than 440,000 Minnesotans rely on SNAP benefits, according to DCYF. More than one-third are children, 18% are seniors and 14% are adults with a disability. If these federal cost shifts and cuts become law, the Minnesota Legislature would likely be forced to return to St. Paul for a special session to either raise taxes, cut services or move money around to fulfill lawmakers' constitutional obligation to balance the budget.
Yahoo
an hour ago
- Yahoo
Dr. Pepper zero recall upgraded in Georgia, South Carolina
SAVANNAH, Ga. (WSAV) — Dr. Pepper is recalling over 19,000 cases of their Zero Sugar soda in three Southern states. The recalled sodas, which are labeled as having zero sugar, actually contained the full sugar product. Because the cans were mislabeled as having zero sugar, they could cause a health risk for diabetics or others who need to limit their sugar intake or avoid it altogether. The voluntary recall was initiated for Zero Sugar Dr. Peppers with a best by date of Feb. 16, 2026, in Georgia, Florida and South Carolina. The sodas were sold in 12-pack and 24-pack cases of 12-ounce cans. The affected product code is XXXXRS05165. The FDA upgraded the recall to Class II last week due to the health risks associated. If you purchased Dr Pepper drinks matching these descriptions, you can return them to the place you purchased them for a full refund or safely dispose of them. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.